Sterling Capital Management LLC Sells 547 Shares of Varian Medical Systems, Inc. (VAR)

Sterling Capital Management LLC cut its holdings in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 15.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,912 shares of the medical equipment provider’s stock after selling 547 shares during the quarter. Sterling Capital Management LLC’s holdings in Varian Medical Systems were worth $331,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Baird Financial Group Inc. lifted its holdings in Varian Medical Systems by 5.7% during the first quarter. Baird Financial Group Inc. now owns 8,006 shares of the medical equipment provider’s stock valued at $981,000 after purchasing an additional 430 shares during the last quarter. First Republic Investment Management Inc. lifted its holdings in Varian Medical Systems by 10.2% during the second quarter. First Republic Investment Management Inc. now owns 5,535 shares of the medical equipment provider’s stock valued at $629,000 after purchasing an additional 511 shares during the last quarter. IFM Investors Pty Ltd lifted its holdings in Varian Medical Systems by 23.6% during the first quarter. IFM Investors Pty Ltd now owns 3,064 shares of the medical equipment provider’s stock valued at $376,000 after purchasing an additional 585 shares during the last quarter. Dynamic Technology Lab Private Ltd lifted its holdings in Varian Medical Systems by 17.3% during the second quarter. Dynamic Technology Lab Private Ltd now owns 3,987 shares of the medical equipment provider’s stock valued at $454,000 after purchasing an additional 587 shares during the last quarter. Finally, SFE Investment Counsel lifted its holdings in Varian Medical Systems by 2.6% during the second quarter. SFE Investment Counsel now owns 30,752 shares of the medical equipment provider’s stock valued at $3,497,000 after purchasing an additional 779 shares during the last quarter. 92.41% of the stock is currently owned by institutional investors and hedge funds.

In other Varian Medical Systems news, SVP John W. Kuo sold 1,327 shares of the stock in a transaction that occurred on Monday, July 16th. The shares were sold at an average price of $115.28, for a total transaction of $152,976.56. Following the transaction, the senior vice president now directly owns 30,548 shares in the company, valued at $3,521,573.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Magnus Momsen sold 2,800 shares of the stock in a transaction that occurred on Tuesday, September 4th. The shares were sold at an average price of $111.68, for a total transaction of $312,704.00. The disclosure for this sale can be found here. Insiders have sold 16,416 shares of company stock worth $1,825,949 over the last quarter. Company insiders own 0.78% of the company’s stock.



Shares of VAR opened at $109.98 on Thursday. The company has a market capitalization of $10.20 billion, a P/E ratio of 25.67, a P/E/G ratio of 3.13 and a beta of 0.79. Varian Medical Systems, Inc. has a 1-year low of $98.34 and a 1-year high of $130.29.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings results on Wednesday, July 25th. The medical equipment provider reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $0.99 by $0.05. Varian Medical Systems had a net margin of 4.07% and a return on equity of 27.51%. The business had revenue of $709.10 million for the quarter, compared to analysts’ expectations of $663.19 million. During the same period last year, the business earned $1.04 earnings per share. The business’s quarterly revenue was up 12.1% on a year-over-year basis. equities analysts anticipate that Varian Medical Systems, Inc. will post 4.45 EPS for the current fiscal year.

Several equities research analysts have commented on the stock. Zacks Investment Research raised shares of Varian Medical Systems from a “sell” rating to a “hold” rating in a report on Wednesday, September 12th. JPMorgan Chase & Co. downgraded shares of Varian Medical Systems from a “neutral” rating to an “underweight” rating and set a $105.00 target price on the stock. in a research note on Thursday, June 28th. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $117.43.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

See Also: What Factors Can Affect Return on Equity?

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply